Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
addiction
Providers
Officials urge buprenorphine uptake following X-Waiver repeal
Loosened DEA requirements have increased the number of providers who can prescribe buprenorphine for opioid use disorder from 130,000 to 1.8 million.
Dave Muoio
Jan 24, 2023 6:00pm
Highmark steps up coverage of prescription digital therapies
Oct 24, 2022 7:40am
Quit Genius moves to full-risk payment model for employers
Jul 13, 2022 9:00am
White House calls for harm reduction resources in drug strategy
Apr 21, 2022 3:48pm
General Catalyst leads addiction startup's $50M series C
Apr 12, 2022 2:40pm
Telehealth has opened up access to addiction recovery: survey
Mar 29, 2022 4:00pm